Figure 1From: Severe pan-uveitis in a patient treated with vemurafenib for metastatic melanoma Gadolinium-enhanced T1-weighted magnetic resonance images of cerebral metastases. A. MRI of the brain before treatment with vemurafenib. B. MRI at presentation with visual loss. C. MRI four weeks after cessation of treatment.Back to article page